HomeNewsBusinessAs scrap stock piles up at ports, importers scamper for waivers, additional storage

As scrap stock piles up at ports, importers scamper for waivers, additional storage

Importers fear an eventual bill of Rs 6,000 crore, as already 1.5 lakh containers are stuck at ports across the country

April 23, 2020 / 13:50 IST
Story continues below Advertisement

The country's scrap importers are in a dilemma.

One the one hand,  they are unable to accept containers that are piling up at ports, and on the other, demand for their products has plummeted leading to a severe cash crunch.

Story continues below Advertisement

And to confound matters further, two separate communications from the Ministry of Shipping has added to the uncertainty.

Over 30 percent of the 1.5 lakh containers that are stuck in ports across the country, contain scrap that are used to make products for auto and construction/infrastructure sectors.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show